|Min SIP Amount||Not Supported|
|NAV||₹10.00 (05 May 2020)|
|Fund Started||27 Mar 2017|
|Fund Size||₹133 Cr|
|IDFC First Bank Ltd.||Financial||Fixed Deposits||15.7%|
|Housing Development Finance Corpn. Ltd.||Financial||Equity||8.3%|
|Reliance Industries Ltd.||Energy||Equity||7.0%|
|JM Financial Asset Reconstruction Company Ltd||Financial||Debenture||6.9%|
|Larsen & Toubro Ltd.||Construction||Equity||5.3%|
|National Bank For Agriculture & Rural Development||Financial||Bonds||3.8%|
|State Bank of India||Financial||Equity||2.1%|
|Mahindra & Mahindra Ltd.||Automobile||Equity||2.0%|
|Tech Mahindra Ltd.||Technology||Equity||1.9%|
HDFC Charity Fund For Cancer Cure Arbitrage Plan Regular Dividend is a Equity Mutual Fund Scheme launched by HDFC Mutual Fund. This scheme was made available to investors on 27 Mar 2017. Krishan Daga, Rakesh Vyas is the Current Fund Manager of HDFC Charity Fund For Cancer Cure Arbitrage Plan Regular Dividend fund.The fund currently has an Asset Under Management(AUM) of ₹133 Cr and the Latest NAV as of 05 May 2020 is ₹10.00.
The HDFC Charity Fund For Cancer Cure Arbitrage Plan Regular Dividend is rated Moderately Low risk.
The scheme aims to generate income through arbitrage opportunities between cash and derivative market and through investments in debt and money market instruments.